LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:LG Life Science LTD (068870) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013613
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LG Life Science LTD (LGLS) is a global life science company that offers development, production and marketing of pharmaceutical products. The company provides pipeline of antibiotic, Factive and other drug candidates. Its products include vaccines, anti-infective, chemicals, veterinary medicine, fine chem, facial aesthetics, viscosupplements, products for hormones and fertility treatment. LGLS offers intermax gamma, intermax alpha, degenerative arthritis treatment, and others. The company’s target therapeutic areas include infectious disease, metabolic disease, urology, oncology, musculoskeletal, endocrinology, infertility, molecular diagnostics and others. It operates through its research center and plant, located in Korea. The company has operational presence in India, Poland, China and Jordan. LGLS is headquartered in Seoul, South Korea.

LG Life Science LTD (068870) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LG Life Science LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
LG Life Science LTD, Medical Devices Deals, 2011 to YTD 2017 9
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
LG Life Science LTD, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Lupin Enters into Distribution Agreement with LG Life Sciences for Insulin Analogue Glargine 11
Precision System Science Enters Into Distribution Agreement With LG Life Sciences 12
Chong Kun Dang Enters Into Distribution Agreement With LG Life Sciences For Uritos 13
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 14
Green Cross Enters Into Co-Promotion Agreement With LG Life Sciences For Shinbaro 15
Licensing Agreements 16
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 16
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic 17
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 18
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir 19
Novavax Enters Into Licensing Agreement With LG Life Sciences 20
LG Life Science LTD – Key Competitors 21
LG Life Science LTD – Key Employees 22
LG Life Science LTD – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
LG Life Science LTD, Pharmaceuticals & Healthcare, Key Facts, 2015 2
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
LG Life Science LTD, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
LG Life Science LTD, Deals By Therapy Area, 2011 to YTD 2017 8
LG Life Science LTD, Medical Devices Deals, 2011 to YTD 2017 9
LG Life Science LTD, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lupin Enters into Distribution Agreement with LG Life Sciences for Insulin Analogue Glargine 11
Precision System Science Enters Into Distribution Agreement With LG Life Sciences 12
Chong Kun Dang Enters Into Distribution Agreement With LG Life Sciences For Uritos 13
LG Life Sciences Enters Into Co-Promotion Agreement With Sanofi-Aventis Korea For Zemiglo 14
Green Cross Enters Into Co-Promotion Agreement With LG Life Sciences For Shinbaro 15
LG Life Sciences Enters into Licensing Agreement with Mochida Pharma 16
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic 17
LG Life Sciences Enters Into License Agreement With Mochida For Biosimilar Antibody Drugs 18
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir 19
Novavax Enters Into Licensing Agreement With LG Life Sciences 20
LG Life Science LTD, Key Competitors 21
LG Life Science LTD, Key Employees 22
LG Life Science LTD, Other Locations 23
LG Life Science LTD, Subsidiaries 23

★海外企業調査レポート[LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PFSweb Inc (PFSW):企業の財務・戦略的SWOT分析
    Summary PFSweb Inc (PFSweb) is an eCommerce solutions provider. Its various services include agency services, marketing services, technology and financial services. The company offers solutions for omnichannel operations, technology ecosystem, and strategic commerce consulting. Its technology ecosys …
  • Decathlon S.A.:企業の戦略・SWOT・財務情報
    Decathlon S.A. - Strategy, SWOT and Corporate Finance Report Summary Decathlon S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Qenos Pty Ltd:企業の戦略的SWOT分析
    Qenos Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Magellan Health, Inc.:企業の戦略・SWOT・財務分析
    Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務分析
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As:企業の戦略・SWOT・財務分析
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • MI Bioresearch Inc-医療機器分野:企業M&A・提携分析
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous m …
  • Ecsponent Limited (ECS):企業の財務・戦略的SWOT分析
    Ecsponent Limited (ECS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Swissquote Group Holding Ltd (SQN):企業の財務・戦略的SWOT分析
    Swissquote Group Holding Ltd (SQN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Reliance General Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The United India Insurance Co Ltd:企業の戦略・SWOT・財務情報
    The United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Taiho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group develops and markets pharmaceutical products in the field of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic agents, anti-tumor agents, H2 receptor …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure disease. The company develops pipeline products such as Atu027 and Atu111. Its Atu027 is developed for the treatment of pancreatic, head and neck cancer …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Academic Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Academic Medical Center (AMC), a subsidiary of University of Amsterdam is a medical center that offers research and educational services. The center offers services such as medical research, treatment of patients, and medical education services, among others. It provides its medical treatmen …
  • Epuron Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary Epuron Pty Ltd (Epuron), formerly Taurus Energy Pty Ltd, a subsidiary of Epuron Holding GmbH & Co KG, is a renewable energy company that develops wind and solar energy projects. The company provides resource monitoring and assessment for wind and solar energy projects including data capture …
  • Sogefi S.p.A:企業の戦略・SWOT・財務情報
    Sogefi S.p.A - Strategy, SWOT and Corporate Finance Report Summary Sogefi S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆